This report provides a comprehensive analysis of the global Ds DNA Bacteriophage market, projecting significant growth through 2032. It examines key market drivers and trends across various applications, including human health, agriculture, and the food industry, while segmenting the landscape by tail structure. Covering major regions such as the Americas, APAC, and Europe, the study evaluates competitive dynamics among leading players like Thermo Fisher and Agilent to identify emerging opportunities and strategic industry developments.

Executive Overview

Market Projections

The global Ds DNA Bacteriophage market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate throughout the forecast period.

Definition and Utility

Bacteriophage (phage) is the general name for viruses that infect bacteria, fungi, algae, actinomycetes, spirochetes, and other microorganisms. They are termed bacteriophages because they can partially cause the lysis of host bacteria, and they find wide utility across various fields of human life.

Regional Market Analysis

Global Outlook

The report provides a comprehensive analysis of the world Ds DNA Bacteriophage industry, including a review of total global sales in 2025 and detailed projections for 2026 through 2032. The analysis is broken down by region, market sector, and sub-sector, providing detailed insights in US$ millions.

Specific Regional Projections

• United States: The market is estimated to increase steadily from 2025 through 2032.
• China: The market is estimated to increase steadily from 2025 through 2032.
• Europe: The market is estimated to increase steadily from 2025 through 2032.

Market Segmentation

By Type

• Tail Structure Bacteriophage
• Tailless Structure Bacteriophage

By Application

• Agriculture
• Food Industry
• Human Health
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Market Dynamics

This Insight Report highlights key trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity. It also analyzes the strategies of leading global companies, focusing on their Ds DNA Bacteriophage portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating market.

In terms of revenue, the global market is characterized by significant concentration, with the two largest companies occupying a substantial portion of the market share in 2025.

Key Players and Profiled Companies

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolios, and market penetration:

• Thermo Fisher
• Agilent
• NPO Microgen
• Proteon Pharmaceuticals
• Phagelux
• Intralytix
• Micreos
• Eliava BioPreparations
• Locus Biosciences, Inc
• Pharmex Group, LLC
• Pherecydes Pharma
• APS Biocontrol Ltd. (APS)
• Qingdao Phagepharm Bio-tech
• Fixed-Phage Limited
• Zeptometrix
• Phage International, Inc.
• MicroMir
• iNtODEWORLD, Inc.
• NEXTBIOTICS
• Armata Pharmaceuticals, Inc.
• Innophage
• Adaptive Phage Therapeutics
• TechnoPhage

Research Methodology

This study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs. It evaluates key market trends, drivers, and affecting factors to shape the global outlook, breaking down forecasts by type, application, geography, and market size to highlight emerging pockets of opportunity.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Ds DNA Bacteriophage Market Size (2021-2032)

    • 2.1.2 Ds DNA Bacteriophage Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Ds DNA Bacteriophage by Country/Region (2021, 2025 & 2032)

  • 2.2 Ds DNA Bacteriophage Segment by Type

    • 2.2.1 Tail Structure Bacteriophage

    • 2.2.2 Tailless Structure Bacteriophage

    • 2.2.3 Ds DNA Bacteriophage Market Size by Type

      • 2.2.3.1 Ds DNA Bacteriophage Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.3.2 Global Ds DNA Bacteriophage Market Size Market Share by Type (2021-2026)

  • 2.3 Ds DNA Bacteriophage Segment by Application

    • 2.3.1 Agriculture

    • 2.3.2 Food lndustry

    • 2.3.3 Human Health

    • 2.3.4 Others

    • 2.3.5 Ds DNA Bacteriophage Market Size by Application

      • 2.3.5.1 Ds DNA Bacteriophage Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.5.2 Global Ds DNA Bacteriophage Market Size Market Share by Application (2021-2026)

• 3 Ds DNA Bacteriophage Market Size by Player

  • 3.1 Ds DNA Bacteriophage Market Size Market Share by Player

    • 3.1.1 Global Ds DNA Bacteriophage Revenue by Player (2021-2026)

    • 3.1.2 Global Ds DNA Bacteriophage Revenue Market Share by Player (2021-2026)

  • 3.2 Global Ds DNA Bacteriophage Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Ds DNA Bacteriophage by Region

  • 4.1 Ds DNA Bacteriophage Market Size by Region (2021-2026)

  • 4.2 Global Ds DNA Bacteriophage Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Ds DNA Bacteriophage Market Size Growth (2021-2026)

  • 4.4 APAC Ds DNA Bacteriophage Market Size Growth (2021-2026)

  • 4.5 Europe Ds DNA Bacteriophage Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Ds DNA Bacteriophage Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Ds DNA Bacteriophage Market Size by Country (2021-2026)

  • 5.2 Americas Ds DNA Bacteriophage Market Size by Type (2021-2026)

  • 5.3 Americas Ds DNA Bacteriophage Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Ds DNA Bacteriophage Market Size by Region (2021-2026)

  • 6.2 APAC Ds DNA Bacteriophage Market Size by Type (2021-2026)

  • 6.3 APAC Ds DNA Bacteriophage Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Ds DNA Bacteriophage Market Size by Country (2021-2026)

  • 7.2 Europe Ds DNA Bacteriophage Market Size by Type (2021-2026)

  • 7.3 Europe Ds DNA Bacteriophage Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Ds DNA Bacteriophage by Region (2021-2026)

  • 8.2 Middle East & Africa Ds DNA Bacteriophage Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Ds DNA Bacteriophage Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Ds DNA Bacteriophage Market Forecast

  • 10.1 Global Ds DNA Bacteriophage Forecast by Region (2027-2032)

    • 10.1.1 Global Ds DNA Bacteriophage Forecast by Region (2027-2032)

    • 10.1.2 Americas Ds DNA Bacteriophage Forecast

    • 10.1.3 APAC Ds DNA Bacteriophage Forecast

    • 10.1.4 Europe Ds DNA Bacteriophage Forecast

    • 10.1.5 Middle East & Africa Ds DNA Bacteriophage Forecast

  • 10.2 Americas Ds DNA Bacteriophage Forecast by Country (2027-2032)

    • 10.2.1 United States Market Ds DNA Bacteriophage Forecast

    • 10.2.2 Canada Market Ds DNA Bacteriophage Forecast

    • 10.2.3 Mexico Market Ds DNA Bacteriophage Forecast

    • 10.2.4 Brazil Market Ds DNA Bacteriophage Forecast

  • 10.3 APAC Ds DNA Bacteriophage Forecast by Region (2027-2032)

    • 10.3.1 China Ds DNA Bacteriophage Market Forecast

    • 10.3.2 Japan Market Ds DNA Bacteriophage Forecast

    • 10.3.3 Korea Market Ds DNA Bacteriophage Forecast

    • 10.3.4 Southeast Asia Market Ds DNA Bacteriophage Forecast

    • 10.3.5 India Market Ds DNA Bacteriophage Forecast

    • 10.3.6 Australia Market Ds DNA Bacteriophage Forecast

  • 10.4 Europe Ds DNA Bacteriophage Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Ds DNA Bacteriophage Forecast

    • 10.4.2 France Market Ds DNA Bacteriophage Forecast

    • 10.4.3 UK Market Ds DNA Bacteriophage Forecast

    • 10.4.4 Italy Market Ds DNA Bacteriophage Forecast

    • 10.4.5 Russia Market Ds DNA Bacteriophage Forecast

  • 10.5 Middle East & Africa Ds DNA Bacteriophage Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Ds DNA Bacteriophage Forecast

    • 10.5.2 South Africa Market Ds DNA Bacteriophage Forecast

    • 10.5.3 Israel Market Ds DNA Bacteriophage Forecast

    • 10.5.4 Turkey Market Ds DNA Bacteriophage Forecast

  • 10.6 Global Ds DNA Bacteriophage Forecast by Type (2027-2032)

  • 10.7 Global Ds DNA Bacteriophage Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Ds DNA Bacteriophage Forecast

• 11 Key Players Analysis

  • 11.1 Thermo Fisher

    • 11.1.1 Thermo Fisher Company Information

    • 11.1.2 Thermo Fisher Ds DNA Bacteriophage Product Offered

    • 11.1.3 Thermo Fisher Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Thermo Fisher Main Business Overview

    • 11.1.5 Thermo Fisher Latest Developments

  • 11.2 Agilent

    • 11.2.1 Agilent Company Information

    • 11.2.2 Agilent Ds DNA Bacteriophage Product Offered

    • 11.2.3 Agilent Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Agilent Main Business Overview

    • 11.2.5 Agilent Latest Developments

  • 11.3 NPO Microgen

    • 11.3.1 NPO Microgen Company Information

    • 11.3.2 NPO Microgen Ds DNA Bacteriophage Product Offered

    • 11.3.3 NPO Microgen Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 NPO Microgen Main Business Overview

    • 11.3.5 NPO Microgen Latest Developments

  • 11.4 Proteon Pharmaceuticals

    • 11.4.1 Proteon Pharmaceuticals Company Information

    • 11.4.2 Proteon Pharmaceuticals Ds DNA Bacteriophage Product Offered

    • 11.4.3 Proteon Pharmaceuticals Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Proteon Pharmaceuticals Main Business Overview

    • 11.4.5 Proteon Pharmaceuticals Latest Developments

  • 11.5 Phagelux

    • 11.5.1 Phagelux Company Information

    • 11.5.2 Phagelux Ds DNA Bacteriophage Product Offered

    • 11.5.3 Phagelux Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Phagelux Main Business Overview

    • 11.5.5 Phagelux Latest Developments

  • 11.6 Intralytix

    • 11.6.1 Intralytix Company Information

    • 11.6.2 Intralytix Ds DNA Bacteriophage Product Offered

    • 11.6.3 Intralytix Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Intralytix Main Business Overview

    • 11.6.5 Intralytix Latest Developments

  • 11.7 Micreos

    • 11.7.1 Micreos Company Information

    • 11.7.2 Micreos Ds DNA Bacteriophage Product Offered

    • 11.7.3 Micreos Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Micreos Main Business Overview

    • 11.7.5 Micreos Latest Developments

  • 11.8 Eliava BioPreparations

    • 11.8.1 Eliava BioPreparations Company Information

    • 11.8.2 Eliava BioPreparations Ds DNA Bacteriophage Product Offered

    • 11.8.3 Eliava BioPreparations Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Eliava BioPreparations Main Business Overview

    • 11.8.5 Eliava BioPreparations Latest Developments

  • 11.9 Locus Biosciences, Inc

    • 11.9.1 Locus Biosciences, Inc Company Information

    • 11.9.2 Locus Biosciences, Inc Ds DNA Bacteriophage Product Offered

    • 11.9.3 Locus Biosciences, Inc Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Locus Biosciences, Inc Main Business Overview

    • 11.9.5 Locus Biosciences, Inc Latest Developments

  • 11.10 Pharmex Group, LLC

    • 11.10.1 Pharmex Group, LLC Company Information

    • 11.10.2 Pharmex Group, LLC Ds DNA Bacteriophage Product Offered

    • 11.10.3 Pharmex Group, LLC Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Pharmex Group, LLC Main Business Overview

    • 11.10.5 Pharmex Group, LLC Latest Developments

  • 11.11 Pherecydes Pharma

    • 11.11.1 Pherecydes Pharma Company Information

    • 11.11.2 Pherecydes Pharma Ds DNA Bacteriophage Product Offered

    • 11.11.3 Pherecydes Pharma Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Pherecydes Pharma Main Business Overview

    • 11.11.5 Pherecydes Pharma Latest Developments

  • 11.12 APS Biocontrol Ltd. (APS)

    • 11.12.1 APS Biocontrol Ltd. (APS) Company Information

    • 11.12.2 APS Biocontrol Ltd. (APS) Ds DNA Bacteriophage Product Offered

    • 11.12.3 APS Biocontrol Ltd. (APS) Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 APS Biocontrol Ltd. (APS) Main Business Overview

    • 11.12.5 APS Biocontrol Ltd. (APS) Latest Developments

  • 11.13 Qingdao Phagepharm Bio-tech

    • 11.13.1 Qingdao Phagepharm Bio-tech Company Information

    • 11.13.2 Qingdao Phagepharm Bio-tech Ds DNA Bacteriophage Product Offered

    • 11.13.3 Qingdao Phagepharm Bio-tech Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Qingdao Phagepharm Bio-tech Main Business Overview

    • 11.13.5 Qingdao Phagepharm Bio-tech Latest Developments

  • 11.14 Fixed-Phage Limited

    • 11.14.1 Fixed-Phage Limited Company Information

    • 11.14.2 Fixed-Phage Limited Ds DNA Bacteriophage Product Offered

    • 11.14.3 Fixed-Phage Limited Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Fixed-Phage Limited Main Business Overview

    • 11.14.5 Fixed-Phage Limited Latest Developments

  • 11.15 Zeptometrix

    • 11.15.1 Zeptometrix Company Information

    • 11.15.2 Zeptometrix Ds DNA Bacteriophage Product Offered

    • 11.15.3 Zeptometrix Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Zeptometrix Main Business Overview

    • 11.15.5 Zeptometrix Latest Developments

  • 11.16 Phage International, Inc.

    • 11.16.1 Phage International, Inc. Company Information

    • 11.16.2 Phage International, Inc. Ds DNA Bacteriophage Product Offered

    • 11.16.3 Phage International, Inc. Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 Phage International, Inc. Main Business Overview

    • 11.16.5 Phage International, Inc. Latest Developments

  • 11.17 MicroMir

    • 11.17.1 MicroMir Company Information

    • 11.17.2 MicroMir Ds DNA Bacteriophage Product Offered

    • 11.17.3 MicroMir Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.17.4 MicroMir Main Business Overview

    • 11.17.5 MicroMir Latest Developments

  • 11.18 iNtODEWORLD, Inc.

    • 11.18.1 iNtODEWORLD, Inc. Company Information

    • 11.18.2 iNtODEWORLD, Inc. Ds DNA Bacteriophage Product Offered

    • 11.18.3 iNtODEWORLD, Inc. Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.18.4 iNtODEWORLD, Inc. Main Business Overview

    • 11.18.5 iNtODEWORLD, Inc. Latest Developments

  • 11.19 NEXTBIOTICS

    • 11.19.1 NEXTBIOTICS Company Information

    • 11.19.2 NEXTBIOTICS Ds DNA Bacteriophage Product Offered

    • 11.19.3 NEXTBIOTICS Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.19.4 NEXTBIOTICS Main Business Overview

    • 11.19.5 NEXTBIOTICS Latest Developments

  • 11.20 Armata Pharmaceuticals, Inc.

    • 11.20.1 Armata Pharmaceuticals, Inc. Company Information

    • 11.20.2 Armata Pharmaceuticals, Inc. Ds DNA Bacteriophage Product Offered

    • 11.20.3 Armata Pharmaceuticals, Inc. Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.20.4 Armata Pharmaceuticals, Inc. Main Business Overview

    • 11.20.5 Armata Pharmaceuticals, Inc. Latest Developments

  • 11.21 Innophage

    • 11.21.1 Innophage Company Information

    • 11.21.2 Innophage Ds DNA Bacteriophage Product Offered

    • 11.21.3 Innophage Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.21.4 Innophage Main Business Overview

    • 11.21.5 Innophage Latest Developments

  • 11.22 Adaptive Phage Therapeutics

    • 11.22.1 Adaptive Phage Therapeutics Company Information

    • 11.22.2 Adaptive Phage Therapeutics Ds DNA Bacteriophage Product Offered

    • 11.22.3 Adaptive Phage Therapeutics Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.22.4 Adaptive Phage Therapeutics Main Business Overview

    • 11.22.5 Adaptive Phage Therapeutics Latest Developments

  • 11.23 TechnoPhage

    • 11.23.1 TechnoPhage Company Information

    • 11.23.2 TechnoPhage Ds DNA Bacteriophage Product Offered

    • 11.23.3 TechnoPhage Ds DNA Bacteriophage Revenue, Gross Margin and Market Share (2021-2026)

    • 11.23.4 TechnoPhage Main Business Overview

    • 11.23.5 TechnoPhage Latest Developments

• 12 Research Findings and Conclusion